BM

Balasubramanian Muhaveni

Active Director Director DIN 10663541
DIN 10663541 First appointment Jun 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Balasubramanian Muhaveni

Data last updated:

Balasubramanian Muhaveni is a Director at Q Genix Pharma Labs Private Limited (since 2024).

DIN 10663541
Primary Designation Director
First Appointment 11 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Q Genix Pharma Labs Private Limited U47721TN2024PTC170942
Director11 Jun 20242024Active

Board colleagues of Balasubramanian Muhaveni

NameDINCompanyDesignation
Gunalan09474770Q Genix Pharma Labs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Q Genix Pharma Labs Private Limited
Premium access

Shareholding and investment profile for Balasubramanian Muhaveni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balasubramanian Muhaveni

Balasubramanian Muhaveni currently holds 1 directorship: Q Genix Pharma Labs Private Limited (Director, since 11 Jun 2024).

Balasubramanian Muhaveni was first appointed on 11 Jun 2024 as Director at Q Genix Pharma Labs Private Limited.

The current boards of Balasubramanian Muhaveni's companies include Gunalan (Q Genix Pharma Labs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available